The upregulation of receptors is characteristic of a majority of cancer types, and triple negative cancers are also of no exception as studies have shown an overexpression of the Epidermal Growth Factor Receptor (EGFR) and numerous cytokeratins amongst these cancer cells [38] thus this overexpression of LRP/LR is not eccentric. The gene discussed is EGFR; the disease is cancer.